Alexion closes in on SEC settlement after five-year probe

The pharmaceutical company has agreed to resolve a foreign bribery investigation by the SEC for under $25 million. The DOJ, meanwhile, has closed its parallel case without enforcement action.

Get unlimited access to all Global Investigations Review content